← Leaderboards
Maria J Worsham
Henry Ford Health System
$2,033,753
Attributed
$2,033,753
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $318.4K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,033,753 · 2
By mechanism
R01$2,033,753 · 2
Top collaborators
No co-investigators on record.
Most similar at Henry Ford Health System
Same institution · by research overlap
- Robert A Chapman$536,921
- Shulin Li$17,068,216
- Irene F Newsham$209,004
- Sandra Ann Rempel$3,374,829
- Keoki Williams$18,740,627
Others in their field
Top investigators on “Biopsy”
- David Heimbrook · Leidos Biomedical Research, Inc.$97,871,847
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ralph Parchment · Leidos Biomedical Research, Inc.$43,674,966
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Peter Scott Heeger · Case Western Reserve University$37,822,090
Research focus
BiopsyNeoplasm /Cancer GeneticsBiomarkerCancer RiskHuman SubjectClinical ResearchBrca GeneAneuploidyDiagnosticCadherinsCellsCohort StudiesCell TransformationChemotherapyAnalytical MethodCohortBreast NeoplasmsClinical ManagementClassificationCritical PathwaysDatabasesDiagnosisBreast Neoplasm /Cancer DiagnosisBase
Grant awards (9)
MOLECULAR MODELING OF DIAGNOSIS AND PROGNOSIS IN HNSCC$65,163
R01 · FY2009 · DE · contact PI
MOLECULAR MODELING OF DIAGNOSIS AND PROGNOSIS IN HNSCC$318,440
R01 · FY2008 · DE · contact PI
MOLECULAR MODELING OF DIAGNOSIS AND PROGNOSIS IN HNSCC$273,076
R01 · FY2007 · DE · contact PI
MOLECULAR MODELING OF DIAGNOSIS AND PROGNOSIS IN HNSCC$281,232
R01 · FY2006 · DE · contact PI
MOLECULAR MODELING OF DIAGNOSIS AND PROGNOSIS IN HNSCC$288,000
R01 · FY2005 · DE
MOLECULAR MODELING OF DIAGNOSIS AND PROGNOSIS IN HNSCC$288,000
R01 · FY2004 · DE
BENIGN BREAST DISEASE--MOLECULAR DIFFERENTIATION OF RISK$113,828
R01 · FY2001 · CA
BENIGN BREAST DISEASE--MOLECULAR DIFFERENTIATION OF RISK$17,046
R01 · FY2001 · CA
BENIGN BREAST DISEASE--MOLECULAR DIFFERENTIATION OF RISK$388,968
R01 · FY2000 · CA